Materials and methods relating to stabilised polymeric silicate compositions

Patent metadata

Field	Value
Publication number	US-10898511-B2
Application number	US-201816169437-A
Country	US
Kind code	B2
Filing date	Oct 24, 2018
Priority date	Feb 14, 2014
Publication date	Jan 26, 2021
Grant date	Jan 26, 2021

Abstract

Stabilised and aquated polymeric silicate compositions are described in which the compositions are poorly condensed compositions in which the silicates are resorbable and are capable of undergoing efficient dissolution to provide bioavailable soluble silicic acid. In particular, stabilised and aquated polymeric silicates are described that are capable of intravenous delivery, useful in the treatment of cancer or systemic infection, or for topical administration, e.g. in the form of a solid or semi-solid ointment useful in the treatment of wounds or the prevention of bacterial infection.

First claim

The invention claimed is:

1. A process for producing a stabilised polymeric silicate composition comprising polymeric silicic acid and nanosilicate particles having mean diameters of 20 nm or less, the process comprising the steps of:
(a) providing an aqueous solution of a soluble silicate at a pH greater than or equal to 9.5;
(b) reducing the pH of the silicate solution to cause polymerisation of the silicate to form polymeric silicic acid and nanosilicate particles, wherein the pH is lowered over a period of less than 60 seconds; and
(c) simultaneously or sequentially with steps (a) and/or (b) adding to the silicate solution a stabilising agent that comprises a polyalkylene glycol and/or a sugar thereby producing a stabilised silicate composition in which the stabilising agent inhibits formation of condensed silicates;
wherein the stabilised polymeric silicate composition is aquated and wherein the process does not involve drying the composition or heating it above 100° C.

2. The process of claim 1 , wherein the stabilised polymeric silicate composition comprises at least 5% water.

3. The process of claim 1 , wherein the process does not involve drying the composition or heating it above 70° C.

4. The process of claim 1 , wherein the stabilised polymeric silicate composition is resorbable as determined in an in vitro dissolution assay in which at least 25%, and optionally at least 35%, of the composition dissolves in 24 hours in HEPES buffer.

5. The process of claim 4 , wherein the in vitro dissolution assay is a molybdic acid assay for determining the soluble silicic acid fraction.

6. The process of claim 1 , which comprises the further step after steps (b) and (c) of raising the pH of the composition to a final pH by adding a base, and optionally waiting for average particle size grow to the desired size and then optionally adding further stabiliser and/or dropping the pH.

7. The process of claim 1 , wherein the base is sodium hydroxide or sodium carbonate.

8. The process of claim 1 , further comprising formulating the stabilised polymeric silicate composition as a cream or ointment for topical administration to a subject.

9. The process of claim 8 , wherein sodium hydroxide is added to adjust the pH of the composition prior to formulating the stabilised polymeric silicate composition as a cream or ointment by mixing with polyalkylene glycol.

10. The process of claim 8 , wherein formulating the stabilised polymeric silicate composition as a cream or ointment comprises mixing it with a solid or semi-solid matrix.

11. The process of claim 10 , wherein the solid or semi-solid matrix comprises one or more polyalkylene glycol polymers or one or more hydroxyethyl cellulose gels.

12. The process of claim 1 , further comprising formulating the stabilised polymeric silicate composition so that it is formulated for oral administration or parenteral administration of silicic acid to a subject.

13. The process of claim 1 , wherein in step (a) the aqueous alkaline silicate solution is a Group 1 or Group 2 metal silicate.

14. The process of claim 1 , wherein in step (b) the pH is reduced to less than or equal to pH 4.0 by adding an acid.

15. The process of claim 1 , wherein in step (c) the pH is reduced to less than or equal to pH 3.0.

16. The process of claim 1 , wherein the concentration of the silicate solution is between 5 mM and 3.0 M.

17. The process of claim 1 , wherein the concentration of the silicate solution is between 0.1 M and 1.5 M.

18. The process of claim 1 , wherein the stabilised polymeric silicate composition is stable for 1 month or more, 2 months or more, 3 months or more, 6 months or more.

19. The process of claim 1 , wherein the nanosilicate particles have a mean diameter of 10 nm or less.

20. The process of claim 1 , wherein the nanosilicate particles have a mean diameter of 5 nm or less.

21. The process of claim 1 , wherein the concentration of the silicate solution is more than 30 mM.

22. The process of claim 1 , wherein in step (a) the pH of the alkaline silicate solution is above pH 11.5.

23. The process of claim 1 , wherein two, three, four or five stabilising agents are added in step (c).

24. The process of claim 1 , wherein the stabilising agent is sucrose or polyethylene glycol (PEG).

25. The process of claim 1 , wherein the stabilising agent is not lactose or mannitol.

26. The process of claim 1 , wherein in step (b) the pH of the composition is lowered to a pH less than or equal to pH 1.5.

27. The process of claim 1 , further comprising adding one or more metal cations to the composition.

28. The process of claim 27 , wherein the metal cation is Cu 2+ , Ag + , Ca 2+ , Mg 2+ , Fe 3+ and/or Zn 2+ .

29. The process of claim 27 , wherein the metal cation provides the composition with antibacterial properties.

30. The process of claim 28 , wherein the metal cation is added to provide a Si to metal ratio of between 100:1 and 10:1.

31. The process of claim 13 , wherein the Group 1 or Group 2 metal silicate is sodium silicate or potassium silicate.

32. The process of claim 30 , wherein the metal cation is added to provide a Si to metal ratio of 20:1.

33. The process of claim 1 , wherein in step (b) the pH is lowered over a period of less than 30 seconds.

34. The process of claim 1 , wherein in step (b) the pH is lowered over a period of less than 10 seconds.

35. The process of claim 1 , wherein in step (b) the pH is lowered over a period of less than 5 seconds.

Assignees

• Res & Innovation Uk

Inventors

• BASTOS Carlos André Passos
• Powell Jonathan Joseph
• Faria Nuno Jorge Rodrigues
• Vis Bradley Michael

Classifications

• C08K3/36

  Silica · CPC title

• A61K9/0014 Primary

  Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title

• A61K33/34

  Copper; Compounds thereof · CPC title

• A61K47/10

  Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

• A61K9/1611

  Inorganic compounds · CPC title